As advances in health monitors are being developed the opportunity for them to be integrated into daily healthcare infrastructure is also expanding. Many healthcare systems are facing increasing budgetary pressure and are finding it hard to make decisions about what treatments to cover. The willingness to pay a fair price for the benefits of healthcare is present; however, the current infrastructure and evaluation process has limitations. Patients can gain different benefits from the same treatments while also incurring the same cost. Drug evaluations are lengthy and complex processes, especially for ones that have multiple indications, sub-populations and formulations to consider. Market restrictions of having one price per brand often leads to access restrictions not allowing patients to benefit fully from the treatments available. Furthermore, costs for non-compliant patients and adverse events are also upheld by current healthcare systems meaning that the cost per benefits are not fully realized. Continuous monitoring of patients could pave the way forward for scalable, accurate and effective payment by result systems that will allow patient benefits to be directly linked to the cost of treatment. If monitors can accurately evaluate the amount of benefit each patient gains from treatment it can effectively remove the need for drug pricing as a whole, only a cost per unit of health would need to be established and healthcare systems would pay for the total benefits gained by the population, similar to how electricity is paid for using a meter. This change could allow drugs to enter markets with fewer restrictions and be used optimally by physicians where they feel they add the most benefit to patients. Furthermore, patient compliance and adverse events would become the financial responsibility of the drug provider, they will need to enforce monitoring, compliance and incentivize on-label use to provide the maximum patient benefits.